UNC Stroke fellow, Dr. Theresa Sevilis, authored a study that recently appeared in Neurology Today.
In February, UNC neurologist Hae Won Shin, MD, and neurosurgeon Eldad Hadar, MD, were the first in the state to implant the NeuroPace RNS System following the medical device’s recent FDA approval. In clinical trials, the NeuroPace system greatly reduced the number of seizures experienced by patients with severe epilepsy.
Todd Cohen, PhD The Alzheimer’s Association is pleased to announce that Todd Cohen, PhD, a researcher from UNC, is the recipient of a $99,722 New Investigator Research Grant. The grant will be used to fund Dr. Cohen’s lab at UNC, which will study tau acetylation (development of tau tangles, a hallmark of Alzheimer’s) and … Continued
RTI International, in partnership with the University of North Carolina at Chapel Hill, has been awarded a cooperative agreement with the Centers for Disease Control and Prevention to conduct muscular dystrophy surveillance in the Piedmont region of North Carolina. Information collected from the population-based surveillance and follow-up will support research to aid improvements in diagnosis, care and policy.
UNC First Hospital in North Carolina and Southeast to Earn Comprehensive Stroke Center Status
UNC Hospitals has been recognized by The Joint Commission and the American Heart Association/American Stroke Association (AHA/ASA) as meeting The Joint Commission’s standards for Disease-Specific Care Comprehensive Stroke Center Certification.